Astellas Pharma Inc. (ALPMY) Investment Research Dashboard
About Astellas Pharma Inc. (ALPMY) stock analysis
Get live ALPMY stock price $13.65, comprehensive Astellas Pharma Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time ALPMY stock data and investment insights.
Loading chart data...
Astellas Pharma Inc. (ALPMY) Overview
Astellas Pharma Inc. (ALPMY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, ALPMY trades at $13.65 with a market capitalization of 24.45B . Over the past 52 weeks, ALPMY has traded between $9.99 and $17.35 , with the current price positioned at approximately 50% of this range . The stock c...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 24.45B
- Current price: $13.65
- 52-week range: $9.99 - $17.35
- P/E ratio: 9.79
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Astellas Pharma Inc. operates as a global pharmaceutical enterprise, specializing in the research, development, manufacturing, and commercialization of a broad spectrum of medicinal products worldwide. The company's diverse pipeline and marketed port...
Company Information
- CEO
- Naoki Okamura
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 14099
Contact Information
- Website
- https://www.astellas.com
- Address
- 2-5-1, Nihonbashi-Honcho
- Country
- JP
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 9.8)
✓ Lower volatility stock (Beta: 0.08) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Astellas Pharma Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Astellas Pharma Inc.
- ⚠Investors should consider how Astellas Pharma Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
24.45B
P/E Ratio (TTM)
9.79
Beta
0.08
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ALPMY with peer companies:
- Price
- $8.42+4.60% (1D)
- Market cap
- 9.93B
- Price
- $1.07+0.00% (1D)
- Market cap
- 12.20B
- Price
- $5.13+0.59% (1D)
- Market cap
- 13.48B
- Price
- $289.16+1.10% (1D)
- Market cap
- 17.75B
- Price
- $42.90+9.94% (1D)
- Market cap
- 24.15B
- Price
- $66.50+0.00% (1D)
- Market cap
- 34.94B
- Price
- $117.42-0.74% (1D)
- Market cap
- 18.72B
- Price
- $12.68+0.00% (1D)
- Market cap
- 11.27B
- Price
- $4.60+0.00% (1D)
- Market cap
- 19.06B
- Price
- $9.88+0.82% (1D)
- Market cap
- 20.28B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.